Business Context and Reporting Period
This Form 8-K, dated May 3, 2011, reports that Applied Materials, Inc. (Applied) entered into a definitive Agreement and Plan of Merger to acquire Varian Semiconductor Equipment Associates, Inc. (Varian). Varian is a leading supplier of ion implantation equipment for semiconductor chip fabrication. The transaction involves a merger of a wholly-owned Applied subsidiary with Varian, with Varian surviving as a wholly-owned subsidiary of Applied.
Key Financial Metrics and Transaction Terms
- Merger Consideration: $63.00 in cash per share of Varian common stock.
- Financing Structure: Applied expects to fund the transaction using existing cash balances and new debt.
- Bridge Facility: A committed one-year senior bridge term loan facility of up to $2.0 billion from JPMorgan Chase, Citigroup, and Morgan Stanley.
- Revolving Credit Facility: A commitment to arrange a new four-year, $1.5 billion senior unsecured revolving credit facility to replace the existing $1.0 billion facility.
- Termination Fees:
- Varian to pay Applied: $147 million (if Varian accepts a superior offer or the board changes its recommendation).
- Applied to pay Varian: $200 million (if the deal fails due to lack of antitrust approvals).
Note: This filing does not provide specific revenue, profit, cash flow, or margin figures for Applied or Varian.
Material Changes and Conditions
The primary material change is the execution of the Merger Agreement. The completion of the transaction is subject to several conditions, including:
- Approval by Varian stockholders.
- Receipt of domestic and foreign antitrust approvals (including under the Hart-Scott-Rodino Act).
- Satisfaction of customary closing conditions.
Varian has agreed not to solicit competing offers and must recommend the merger to its stockholders.
Outlook, Risks, and Management Commentary
Management anticipates financing the deal through a mix of cash and debt, with specific commitments secured for bridge and revolving facilities. The filing includes standard forward-looking statement disclaimers regarding the ability to consummate the merger, secure regulatory approvals, and complete financing arrangements. Risks include potential litigation, failure to obtain antitrust clearance, and the possibility that the merger may not be completed in a timely manner or at all.
Investor Verification Checklist
- Verify the total equity value of Varian based on the $63 per share offer and outstanding share count.
- Confirm the status of antitrust regulatory approvals required for the merger.
- Review the definitive proxy statement (to be filed by Varian) for detailed financial data and risk factors.
- Monitor the execution of the $2.0 billion bridge loan and the $1.5 billion revolving credit facility.
- Assess the impact of the $147 million and $200 million termination fees on potential deal outcomes.